Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Leflunomide × Clear all

NCT02509052 2023-10-10

Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

12 enrolled 21 charts

Multiple Myeloma